Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8596278 Nasal devices

Patent 8596278 was granted and assigned to OptiNose on December, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 11 Sep, 2024

"update inverses"

Golden AI

edited on 11 Sep, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12083270 Delivery device and method

Edits on 9 Feb, 2024

"update inverses"

Golden AI

edited on 9 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11890412 Nozzles for nasal drug delivery

Edits on 30 Jan, 2024

"update inverses"

Golden AI

edited on 30 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11878110 Intranasal device with inlet interface

"update inverses"

Golden AI

edited on 30 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11878109 Single-use nasal delivery device

Edits on 20 Sep, 2023

"update inverses"

Golden AI

edited on 20 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11759585 Nasal drug delivery device with detachable nozzle

Edits on 13 Sep, 2023

"update inverses"

Golden AI

edited on 13 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11752100 Intranasal delivery of olanzapine by precision olfactory device

Edits on 26 Jul, 2023

"update inverses"

Golden AI

edited on 26 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11707586 Intranasal administration

Edits on 5 Jul, 2023

"update inverses"

Golden AI

edited on 5 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11690969 Delivery of gases to the nasal airway

"update inverses"

Golden AI

edited on 5 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11690819 Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease

Edits on 25 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 25 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 08596278 Nasal devices US Patent 8596278 Nasal devices

Infobox

Patent Number

0859627800

Patent Number

859627800

Edits on 25 Mar, 2023

"Entity importer update"

Golden AI

edited on 25 Mar, 2023

Infobox

Is a

Patent

Current Assignee

OptiNose

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

085962780

Date of Patent

December 3, 2013

Patent Application Number

104691060

Date Filed

February 26, 2002

Patent Primary Examiner

‌

Annette Dixon

Edits on 24 Sep, 2022

"Entity importer update"

Golden AI

edited on 24 Sep, 2022

Infobox

Is a

Patent

Current Assignee

OptiNose

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

085962780

Date of Patent

December 3, 2013

Patent Application Number

104691060

Date Filed

February 26, 2002

Patent Primary Examiner

‌

Annette Dixon

Edits on 21 Dec, 2021

"Created via: Entity Importer"

Golden AI

created this topic on 21 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 08596278 Nasal devices

Infobox

Is a

Patent

Current assignee

OptiNose

Patent jurisdiction

United States Patent and Trademark Office

Patent number

08596278

Date of patent

December 3, 2013

Patent application number

10469106

Date Filed

February 26, 2002

Patent primary examiner

‌

Annette Dixon

Find more entities like US Patent 8596278 Nasal devices

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API